Delahunt B, Eble J N, McCredie M R, Bethwaite P B, Stewart J H, Bilous A M
Department of Pathology and Molecular Medicine, Wellington School of Medicine, University of Otago, Wellington, New Zealand.
Hum Pathol. 2001 Jun;32(6):590-5. doi: 10.1053/hupa.2001.24984.
Whereas papillary renal cell carcinoma is now established as a subtype of renal cell neoplasia, division of these tumors into 2 distinctive morphotypes has been proposed. Type 1 tumors have cells with scanty pale cytoplasm arranged in a single layer on the basement membrane of papillary cores. In these tumors, psammoma bodies and foamy macrophages are frequently seen, and the tumors frequently express cytokeratin 7. Type 2 tumor cells have pseudostratified nuclei and usually have voluminous eosinophilic cytoplasm. Recent studies have supported this subclassification of papillary renal cell carcinoma by demonstrating differing genotypes for type 1 and 2 tumors. To further study the subclassification of papillary renal carcinoma, we compared clinical features, nuclear grade, stage, tumor growth kinetics, and survival in a series of 50 type 1 and 16 type 2 papillary renal cell carcinomas. Comparison of patient age at presentation, sex, and primary tumor size shows no significant difference between the 2 tumor types. Type 1 tumors were of significantly lower Fuhrman grade (P =.0001) and higher Robson stage (P =.009) than type 2 tumors. There was no significant difference when tumors were staged according to the TNM classification. Assessment of tumor growth kinetics showed significantly different mean silver-staining nucleolar organizer region (AgNOR) scores and Ki-67 indices (AgNOR type 1, 3.83, type 2, 7.24, P =.0001; Ki-67 type 1, 3.17%, type 2, 6.01%, P =.0002). Multivariate analysis showed tumor type (P =.03), presence of metastases (P =.04), AgNOR score (P =.001), and Ki-67 index (P =.03) to be independently associated with survival. These results provide evidence of the clinical utility of dividing papillary renal cell carcinomas into 2 types according to histologic characteristics.
鉴于乳头状肾细胞癌现已被确立为肾细胞肿瘤的一种亚型,有人提出将这些肿瘤分为两种不同的形态类型。1型肿瘤的细胞胞质淡染且稀少,单层排列于乳头核心的基底膜上。在这些肿瘤中,常可见到砂粒体和泡沫状巨噬细胞,且肿瘤常表达细胞角蛋白7。2型肿瘤细胞具有假复层核,通常具有丰富的嗜酸性胞质。最近的研究通过证明1型和2型肿瘤具有不同的基因型,支持了乳头状肾细胞癌的这种亚分类。为了进一步研究乳头状肾癌的亚分类,我们比较了50例1型和16例2型乳头状肾细胞癌的临床特征、核分级、分期、肿瘤生长动力学和生存率。比较患者就诊时的年龄、性别和原发肿瘤大小,发现这两种肿瘤类型之间无显著差异。1型肿瘤的Fuhrman分级显著低于2型肿瘤(P = 0.0001),而Robson分期则高于2型肿瘤(P = 0.009)。根据TNM分类进行分期时,两种肿瘤之间无显著差异。肿瘤生长动力学评估显示,平均银染核仁组成区(AgNOR)评分和Ki-67指数有显著差异(AgNOR 1型为3.83,2型为7.24,P = 0.0001;Ki-67 1型为3.17%,2型为6.01%,P = 0.0002)。多变量分析显示,肿瘤类型(P = 0.03)、转移情况(P = 0.04)、AgNOR评分(P = 0.